BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 16790086)

  • 1. Gene expression profile related to the progression of preneoplastic nodules toward hepatocellular carcinoma in rats.
    Pérez-Carreón JI; López-García C; Fattel-Fazenda S; Arce-Popoca E; Alemán-Lazarini L; Hernández-García S; Le Berre V; Sokol S; Francois JM; Villa-Treviño S
    Neoplasia; 2006 May; 8(5):373-83. PubMed ID: 16790086
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mybl2 expression is under genetic control and contributes to determine a hepatocellular carcinoma susceptible phenotype.
    Frau M; Ladu S; Calvisi DF; Simile MM; Bonelli P; Daino L; Tomasi ML; Seddaiu MA; Feo F; Pascale RM
    J Hepatol; 2011 Jul; 55(1):111-9. PubMed ID: 21419759
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative analysis of hepatic hypoxia-inducible factor-1alpha and its abnormal gene expression during the formation of hepatocellular carcinoma.
    Yao DF; Jiang H; Yao M; Li YM; Gu WJ; Shen YC; Qiu LW; Wu W; Wu XH; Sai WL
    Hepatobiliary Pancreat Dis Int; 2009 Aug; 8(4):407-13. PubMed ID: 19666411
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Specific patterns of PIWI-interacting small noncoding RNA expression in dysplastic liver nodules and hepatocellular carcinoma.
    Rizzo F; Rinaldi A; Marchese G; Coviello E; Sellitto A; Cordella A; Giurato G; Nassa G; Ravo M; Tarallo R; Milanesi L; Destro A; Torzilli G; Roncalli M; Di Tommaso L; Weisz A
    Oncotarget; 2016 Aug; 7(34):54650-54661. PubMed ID: 27429044
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative analysis of expression profiling of early-stage carcinogenesis using nodule-in-nodule-type hepatocellular carcinoma.
    Nam SW; Lee JH; Noh JH; Lee SN; Kim SY; Lee SH; Park CK; Ahn YM; Park WS; Yoo NJ; Lee JY
    Eur J Gastroenterol Hepatol; 2006 Mar; 18(3):239-47. PubMed ID: 16462536
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular changes from dysplastic nodule to hepatocellular carcinoma through gene expression profiling.
    Nam SW; Park JY; Ramasamy A; Shevade S; Islam A; Long PM; Park CK; Park SE; Kim SY; Lee SH; Park WS; Yoo NJ; Liu ET; Miller LD; Lee JY
    Hepatology; 2005 Oct; 42(4):809-18. PubMed ID: 16175600
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transferrin and transferrin receptor gene expression and iron uptake in hepatocellular carcinoma in the rat.
    Pascale RM; De Miglio MR; Muroni MR; Simile MM; Daino L; Seddaiu MA; Pusceddu S; Gaspa L; Calvisi D; Manenti G; Feo F
    Hepatology; 1998 Feb; 27(2):452-61. PubMed ID: 9462644
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A molecular signature to discriminate dysplastic nodules from early hepatocellular carcinoma in HCV cirrhosis.
    Llovet JM; Chen Y; Wurmbach E; Roayaie S; Fiel MI; Schwartz M; Thung SN; Khitrov G; Zhang W; Villanueva A; Battiston C; Mazzaferro V; Bruix J; Waxman S; Friedman SL
    Gastroenterology; 2006 Dec; 131(6):1758-67. PubMed ID: 17087938
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolic reprogramming identifies the most aggressive lesions at early phases of hepatic carcinogenesis.
    Kowalik MA; Guzzo G; Morandi A; Perra A; Menegon S; Masgras I; Trevisan E; Angioni MM; Fornari F; Quagliata L; Ledda-Columbano GM; Gramantieri L; Terracciano L; Giordano S; Chiarugi P; Rasola A; Columbano A
    Oncotarget; 2016 May; 7(22):32375-93. PubMed ID: 27070090
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methylated chrysin induces co-ordinated attenuation of the canonical Wnt and NF-kB signaling pathway and upregulates apoptotic gene expression in the early hepatocarcinogenesis rat model.
    Khan MS; Halagowder D; Devaraj SN
    Chem Biol Interact; 2011 Aug; 193(1):12-21. PubMed ID: 21554863
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of autophagy promotes the growth of early preneoplastic rat liver nodules.
    Kowalik MA; Perra A; Ledda-Columbano GM; Ippolito G; Piacentini M; Columbano A; Falasca L
    Oncotarget; 2016 Feb; 7(5):5788-99. PubMed ID: 26735341
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The expression of transforming growth factor-alpha in cirrhosis, dysplastic nodules, and hepatocellular carcinoma: an immunohistochemical study of 70 cases.
    Yeh MM; Larson AM; Campbell JS; Fausto N; Rulyak SJ; Swanson PE
    Am J Surg Pathol; 2007 May; 31(5):681-9. PubMed ID: 17460450
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinicopathologic significance of mitotic arrest defective protein 2 overexpression in hepatocellular carcinoma.
    Zhang SH; Xu AM; Chen XF; Li DH; Sun MP; Wang YJ
    Hum Pathol; 2008 Dec; 39(12):1827-34. PubMed ID: 18715617
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alterations of p53, Bcl-2, and hMSH2 protein expression in the cirrhotic, macroregenerative, dysplastic nodules and hepatocellular carcinomas in Upper Egypt.
    Hussein MR
    Liver Int; 2004 Dec; 24(6):552-60. PubMed ID: 15566504
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA/gene profiling unveils early molecular changes and nuclear factor erythroid related factor 2 (NRF2) activation in a rat model recapitulating human hepatocellular carcinoma (HCC).
    Petrelli A; Perra A; Cora D; Sulas P; Menegon S; Manca C; Migliore C; Kowalik MA; Ledda-Columbano GM; Giordano S; Columbano A
    Hepatology; 2014 Jan; 59(1):228-41. PubMed ID: 23857252
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differentially expressed genes associated with hepatitis B virus HBx and MHBs protein function in hepatocellular carcinoma.
    Kim DG
    Methods Mol Biol; 2006; 317():141-55. PubMed ID: 16264227
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression profiling in multistage hepatocarcinogenesis: identification of HSP70 as a molecular marker of early hepatocellular carcinoma.
    Chuma M; Sakamoto M; Yamazaki K; Ohta T; Ohki M; Asaka M; Hirohashi S
    Hepatology; 2003 Jan; 37(1):198-207. PubMed ID: 12500205
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thyroid hormone inhibits hepatocellular carcinoma progression via induction of differentiation and metabolic reprogramming.
    Kowalik MA; Puliga E; Cabras L; Sulas P; Petrelli A; Perra A; Ledda-Columbano GM; Morandi A; Merlin S; Orrù C; Sanchez-Martin C; Fornari F; Gramantieri L; Parri M; Rasola A; Bellomo SE; Sebastian C; Follenzi A; Giordano S; Columbano A
    J Hepatol; 2020 Jun; 72(6):1159-1169. PubMed ID: 31954205
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of genes associated with multiple nodules in hepatocellular carcinoma using cDNA microarray: multicentric occurrence or intrahepatic metastasis?
    Nakata T; Seki N; Miwa S; Kobayashi A; Soeda J; Nimura Y; Kawasaki S; Miyagawa S
    Hepatogastroenterology; 2008; 55(84):865-72. PubMed ID: 18705285
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An expression signature of phenotypic resistance to hepatocellular carcinoma identified by cross-species gene expression analysis.
    Frau M; Simile MM; Tomasi ML; Demartis MI; Daino L; Seddaiu MA; Brozzetti S; Feo CF; Massarelli G; Solinas G; Feo F; Lee JS; Pascale RM
    Cell Oncol (Dordr); 2012 Jun; 35(3):163-73. PubMed ID: 22434528
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.